×
OSR Holdings EBITDA 2022-2025 | OSRH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
OSR Holdings ebitda from 2022 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
OSR Holdings EBITDA 2022-2025 | OSRH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
OSR Holdings ebitda from 2022 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$148.7B
CVS Health (CVS)
$90.3B
Elevance Health (ELV)
$70.7B
Cencora (COR)
$55.9B
DiDi Global (DIDIY)
$26.8B
Labcorp Holdings (LH)
$22.9B
Natera (NTRA)
$22.3B
BioMerieux (BMXMF)
$17.4B
EUROFINS SCIENT (ERFSF)
$15B
ICON (ICLR)
$13.9B
Medpace Holdings (MEDP)
$13.1B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$12.6B
Viatris (VTRS)
$12.3B
Caris Life Sciences,�Inc (CAI)
$10.8B
Revvity (RVTY)
$10.7B
Avantor (AVTR)
$9B
Charles River Laboratories (CRL)
$8.1B
Sonic Healthcare (SKHHY)
$7.7B
HealthEquity (HQY)
$7.6B
Bausch + Lomb (BLCO)
$5.1B
Sotera Health (SHC)
$4.7B
BrightSpring Health Services (BTSG)
$4.3B
Amplifon S.p.A (AMFPF)
$3.9B
GeneDx Holdings (WGS)
$3.5B
KindlyMD (NAKA)
$3.4B
Alignment Healthcare (ALHC)
$3.1B
Concentras Parent (CON)
$3B
Surgery Partners (SGRY)
$3B
Organon (OGN)
$2.4B